Phone: Resource Center
The Rising Value of Medical Affairs – Engagement with External Stakeholders (KOLs, TLs, EEs)
AUTHOR: N. Borinshteyn
The ever-evolving relationship between the pharmaceutical industry and its key opinion leaders (KOLs) has been a hot topic for a while, and there are several…CONTINUE READING
Launch Excellence: Is It Achievable?
AUTHOR: CMK SELECT
The numbers are dramatic: 50% of pharma launches fail to meet forecasts, with 25% widely missing the mark. If you’re in a pre-launch phase, with…CONTINUE READING
Do Brands Have Value After Exclusivity?
AUTHOR: I. Deza
When a successful product is about to lose its exclusivity, and is facing incursions by generics or biosimilars, a pharmaceutical manufacturer sometimes decides to walk…CONTINUE READING
Medical Events Compliance
AUTHOR: CMK SELECT
A major pharmaceutical company was in need of a review and approval process to help streamline the planning and execution of its external medical events.…CONTINUE READING
Co-Promotion Optimization
AUTHOR: CMK SELECT
A notable pharmaceutical company had agreed to co-promote a drug and, in turn, was obligated to provide a list of contractual deliverables to the partner…CONTINUE READING
The Continuously Increasing Value of Medical Affairs in Product Launches – Part II
AUTHOR: N. Borinshteyn
As we’ve already begun to look into in Part I of this two-part blog, Medical Affairs teams play a critical role in bringing new treatment…CONTINUE READING
The Continuously Increasing Value of Medical Affairs in Product Launches – Part I
AUTHOR: N. Borinshteyn
Bringing each new pharmaceutical product to market is a complex and somewhat unique process led and executed by a cross-functional team who undertakes a number…CONTINUE READING
Case for an IT-enabling Business Strategy for companies in the Life Sciences Industry
AUTHOR: D. Douglas
The major trends in the life sciences industry are profoundly affecting the way we all work – from conducting research to distributing products, and everything…CONTINUE READING
Expense Report Compliance Audit
AUTHOR: CMK SELECT
A major pharmaceutical company engaged CMK Select to create a streamlined process for submitting, processing and approving monthly expense reports generated from their sales team’s…CONTINUE READING
Clinical Data Standards
AUTHOR: CMK SELECT
Following the December 17, 2014, FDA binding guidance that all pharma studies starting after December 17, 2016, must conform to a set of FDA-sponsored standards,…CONTINUE READING